Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “t-cell”

88 pharma patents match "t-cell" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 88
Index total 30,257
Page 3 / 4

Quick answer

This filtered view shows 88 pharmaceutical patents matching "t-cell" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

88 results for “t-cell” · 30,257 patents in full index Clear search

  1. US 11344577

    Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA

    The Board of Regents of the University of Texas System · Granted May 31, 2022 · Expires May 26, 2042

    granted
  2. US 11161908

    BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted
  3. US 11154573

    Methods of generating T-cells from stem cells and immunotherapeutic methods using the T-cells

    The Regents of the University of California · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  4. US 11117945

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted
  5. US 11078252

    T-cell receptor

    University College Cardiff Consultants Limited · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  6. US 11008314

    Compounds and methods for modulating interleukin-2-inducible t-cell kinase

    Corvus Pharmaceuticals, Inc. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  7. US 10993959

    Methods and compositions for increasing the suppressive function of regulatory T-cells (Tregs)

    Regents of the University of Minnesota · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  8. US 10927158

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  9. US 10874727

    Inducible regulatory t-cell generation for hematopoietic transplants

    Regents of the University of Minnesota · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  10. US 10633445

    T-cell receptor (TCR)-binding antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  11. US 10633451

    Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine

    Ludwig-Maximilians-Universitat Munchen · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  12. US 10562975

    CD6 antibody for treatment of T-cell mediated diseases or disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  13. US 10407484

    Compositions and methods for modulating T-cell mediated immune response

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 10, 2019 · Expires Sep 5, 2039

    granted
  14. US 10391126

    CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA

    The Board of Regents of the University of Texas System · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted
  15. US 9649339

    LAT adapter molecule for enhanced T-cell signaling and method of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 16, 2017 · Expires May 11, 2037

    granted
  16. US 9645147

    Recombinant polypeptide construct comprising Plasmodium falciparum circumsporozoite protein HLA class I restricted T-cell epitopes

    United States of America as represented by the Secretary of the Air Force · Granted May 9, 2017 · Expires May 4, 2037

    granted
  17. US 9629877

    Human application of engineered chimeric antigen receptor (CAR) T-cells

    The Board of Regents of the University of Texas System · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  18. US 9572873

    Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins

    The Regents of the University of California · Granted Feb 21, 2017 · Expires Feb 16, 2037

    granted
  19. US 9512401

    B and T lymphocyte attenuator marker for use in adoptive T-cell therapy

    The Board of Regents of the University of Texas System · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  20. US 9481866

    Methods of producing T cell populations enriched for stable regulatory T-cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  21. US 9301947

    Ryanodine receptor inhibitors for treatment of T-cell mediated disorders

    The Regents of the University of California · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted
  22. US 9243051

    Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells

    United States Government as represented by the Department of Veterans Affairs · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  23. US 9228172

    Inducible regulatory T-cell generation for hematopoietic transplants

    Regents of the University of Minnesota · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  24. US 9084762

    T-cell immunogens derived from anti-viral proteins and methods of using same

    The Regents of the University of California · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted